Michelson's VivoSight moves into Japan
This article was originally published in Clinica
UK imaging company Michelson Diagnostics has appointed Integral Corporation exclusive distributor of its recently CE-marked VivoSight scanner in Japan. Tokyo-based Integral will market and sell the system, which uses multi-Beam optical coherence tomography, for non-clinical use in cosmetic research settings. The VivoSight was CE marked in October for clinical use in Europe and non-clinical use worldwide. The scanner is designed to provide images of sub-surface tissue at a "far higher" resolution than other imaging modalities, according to Orpington-based Michelson. When positioned over tissue, the system's hand-held probe can capture either two- or three-dimensional images of a 5mm square region and highlight tissue microstructure features such as epidermis, dermis and sub-surface blood vessels.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.